Foley Hoag lawyers and healthcare specialists have decades of experience in statutory and regulatory analysis, compliance, government investigations, litigation and corporate transactions. Our fluency in healthcare laws and policy allows us to help our clients develop successful strategies for navigating the complex healthcare environment.
Intelligencia AI™ leads the way in leveraging proprietary data, biomedical expertise and artificial intelligence (AI) with its patented technology to address significant challenges in the pharmaceutical industry. These challenges include lengthy drug development timelines, excessive costs, and unsustainable return on investment (ROI). Its suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug's probability of success.
Wilson Sonsini is a trusted advisor to trailblazers in the life sciences industry. Our mission is to facilitate the success of companies shaping the future of healthcare, and to help them navigate the complex legal landscape as AI and other new emerging technologies continue to evolve.
Weave uses AI to automate the cumbersome drafting of regulatory submissions, starting with INDs, to safely accelerate drug development from research laboratory to clinic.
Course5 Intelligence enables Life Sciences businesses to thrive by integrating a deep understanding of disease areas, patients, and healthcare professionals (HCPs) with advanced data science, analytics, and AI technologies.
At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we how we live. It is our culture of care, embodied by our patient value strategy.
Forest Hill Labs is a “Skunkworks” in healthcare consulting. A business hyper-focused on realizing opportunities and avoiding threats as a service offering. We create value for clients by thinking and acting ahead of lawmakers, markets, and the public.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
The Shakudo team comprises experts in the fields of data and AI, who are passionate about building an operating system for the modern data stack. They are committed to fostering an inclusive and diverse culture, where everyone is empowered to bring their unique perspective and skills to the table. Together, they are shaping the future of data and AI for commercial use.
TriNetX provides real-world data and real-time global data for researchers to analyze within their own environment. Its world-class consulting team partners with you to drive insight and help answer your most pressing challenges. They are proud that everything TriNetX and the TriNetX community accomplish is in support of our company vision: connecting the world to improve human health.
ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage leading-edge analytics, data and science to help clients make intelligent decisions.
JN Nova is a pre-clinical-stage biopharmaceutical company, focused on efficiently developing innovative treatments that address significant unmet medical needs.
Epikast partners with biopharmaceutical companies as they engage their most important stakeholders: patients and their caregivers.
Pepticom designs novel peptide drug candidates, utilizing unique biocomputational AI software, to optimize the discovery process, accelerate time to market and reduce development risks and costs.
Biotx.ai enables the selection of drug candidates most likely to succeed in phase IIb by combining expert judgment, mechanistic validation and artificial intelligence.
Altis Labs has a mission to accelerate the development of life-changing therapies that improve patient outcomes.
Aitia reveals the hidden biological mechanisms of disease to discover the next generation of breakthrough drugs, improving outcomes for patients by creating Digital Twins of human disease from multi-omic patient data and causal AI.